Champions Oncology
Quarterly Financials
| Values in thousands | 2024-07-31 | 2024-04-30 | 2024-01-31 | 2023-10-31 |
|---|---|---|---|---|
Revenue | $14,061 | $14,001 | $12,019 | $11,573 |
Gross Profit | 6,989 | 6,751 | 4,170 | 4,955 |
EBITDA | 1,778 | 621 | -2,096 | -1,471 |
EBIT | 1,329 | 164 | -3,359 | -1,955 |
Net Income | 1,313 | -109 | -2,530 | -2,071 |
Net Change In Cash | 14,061 | 14,001 | 12,019 | 11,573 |
Free Cash Flow | 311 | -1,705 | -1,045 | 436 |
Cash | 2,892 | 2,618 | 4,468 | 5,513 |
Basic Shares | 14,042 | 13,593 | 13,593 | 13,497 |
Annual Financials
| Values in thousands | 2024-04-30 | 2023-04-30 | 2022-04-30 | 2021-04-30 |
|---|---|---|---|---|
Revenue | $50,155 | $53,870 | $49,109 | $41,040 |
Gross Profit | 20,754 | 24,338 | 25,477 | 19,566 |
EBITDA | -5,054 | -2,069 | 2,234 | 366 |
EBIT | -6,921 | -5,267 | -179 | -1,216 |
Net Income | -7,276 | -5,335 | 548 | 362 |
Net Change In Cash | 50,155 | 53,870 | 49,109 | 41,040 |
Cost of Revenue | 1,111 | 4,320 | -3,655 | |
Free Cash Flow | -6,973 | 1,083 | 4,113 | -4,962 |
Cash | 2,618 | 10,118 | 9,007 | 4,687 |
Basic Shares | 13,547 | 13,541 | 14,159 | 14,573 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-07-31 | $0.11 |
2024-04-30 | $0.01 |
2024-01-31 | -$0.16 |
2023-10-31 | -$0.15 |
